&sq=Facebook&lang=en&file=File:SYNTHON_LOGO_1COLOR_DARKER_RGB.png){kind=logo} | |
| Industry | Pharmaceutical |
|---|---|
| Founded | September 17, 1991 in Nijmegen, Gelderland, The Netherlands |
| Founder | Dr. Jacques Lemmens |
| Headquarters | , |
Key people | CEO Anish Mehta |
| Products | Pharmaceutical |
Number of employees | 1,600 (2022) |
| Website | www |
Synthon is a Dutch multinational that produces generic human drugs.
The company was founded in 1991 by Jacques Lemmens and Marijn Oosterbaan, two organic chemists of the Radboud University Nijmegen. Synthon is active in the Netherlands, the Czech Republic, Spain, the United States, Argentina, Chile, Russia, Mexico and South Korea with about 1,500 employees. The company is headquartered in Nijmegen.
Medications made by Synthon include:
- Simvastatin[1] (A statin)
- Tamsulosin (An alpha blocker for the symptomatic treatment of benign prostatic hyperplasia)
- Paroxetine[2] (An antidepressant)
- Fluvoxamine (An antidepressant)
The products are marketed by partners of the company. The name Synthon is not mentioned on the packaging.